omniture
无锡帕母医疗技术有限公司

Latest News

Pulnovo Medical Announces First Enrollment in Singapore for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

SHANGHAI, Aug. 9, 2024 /PRNewswire/ -- Pulnovo Medical Limited,a globally recognized device pioneer...

2024-08-09 17:09 4788

Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee

SHANGHAI, July 9, 2024 /PRNewswire/ -- Pulnovo Medical, a globally recognized device pioneer in the...

2024-07-09 20:00 1945

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

SHANGHAI, July 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pionee...

2024-07-02 19:10 2239

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pionee...

2024-01-02 20:30 2115

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

SHANGHAI, March 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platfor...

2023-03-28 20:30 1733

Pulnovo Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform...

2023-02-28 10:19 1819

Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board

SHANGHAI, Jan. 14, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform...

2023-01-14 22:00 3773

Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board

SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform,...

2023-01-04 10:46 2284

Pulnovo Medical will be attending JPM Healthcare Conference 2023

SHANGHAI, Dec. 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-12-24 20:00 3992

Pulnovo Medical Inhales Tens of Millions Dollars Funding to Accelerate Global Growth

SHANGHAI, Nov. 7, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM (From Ope...

2022-11-07 20:30 2682

Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH)

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platfor...

2022-09-20 20:30 2114

Pulnovo Medical Concludes Successfully the First Steering Committee Meeting

SHANGHAI, Sept. 8, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-09-08 20:30 1370

Pulnovo Medical Limited's PADN Technology Included in 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH

SHANGHAI, Sept. 7, 2022 /PRNewswire/ -- A globally recognized OTM innovative platform Pulnovo Medic...

2022-09-07 20:30 3018

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

SHANGHAI, July 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pione...

2022-07-15 20:30 4773

Pulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board

SHANGHAI, June 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-06-15 10:00 2605

SCAI & CBS Pulmonary Hypertension Masterclass 2022: Based on Global Perspectives Focusing on New Breakthroughs

SHANGHAI, May 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovativ...

2022-05-24 08:30 2169

Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO

SHANGHAI, March 10, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovat...

2022-03-10 20:00 2521

Pulnovo Medical Announced Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH) Meet The Efficacy Primary Endpoint

SHANGHAI, Jan. 1, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pionee...

2022-01-01 20:30 2738